Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
Birgit Girshick
CEOBirgit Girshick
Employees
19,700
Employees19,700
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
19,700
Employees19,700

CRL Key Statistics

Market cap
8.91B
Market cap8.91B
Price-Earnings ratio
-49.20
Price-Earnings ratio-49.20
Dividend yield
Dividend yield
Average volume
742.89K
Average volume742.89K
High today
$186.18
High today$186.18
Low today
$182.00
Low today$182.00
Open price
$184.10
Open price$184.10
Volume
1.17M
Volume1.17M
52 Week high
$228.88
52 Week high$228.88
52 Week low
$144.26
52 Week low$144.26

Stock Snapshot

As of today, Charles River(CRL) shares are valued at $185.00. The company's market cap stands at 8.91B, with a P/E ratio of -49.20.

On 2026-06-21, Charles River(CRL) stock moved within a range of $182.00 to $186.18. With shares now at $185.00, the stock is trading +1.6% above its intraday low and -0.6% below the session's peak.

Trading activity shows a volume of 1.17M, compared to an average daily volume of 742.89K.

The stock's 52-week range extends from a low of $144.26 to a high of $228.88.

The stock's 52-week range extends from a low of $144.26 to a high of $228.88.

CRL News

Simply Wall St 16h
Charles River Laboratories International Stock Could Be 41% Undervalued After Lilly Tie Up And Upgrade

Advertisement Charles River Laboratories International stock reacts to new AI drug discovery collaboration Charles River Laboratories International (CRL) is b...

Charles River Laboratories International Stock Could Be 41% Undervalued After Lilly Tie Up And Upgrade
MarketWatch 3d
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 4d
What Charles River Laboratories's Morgan Stanley Upgrade Means For Shareholders

In recent days, Morgan Stanley upgraded Charles River Laboratories International to Overweight from Equal Weight, signaling a shift in its analyst assessment of...

What Charles River Laboratories's Morgan Stanley Upgrade Means For Shareholders

Analyst ratings

75%

of 20 ratings
Buy
75%
Hold
20%
Sell
5%

More CRL News

TipRanks 5d
Charles River upgraded to Overweight from Equal Weight at Morgan Stanley

Morgan Stanley upgraded Charles River (CRL) to Overweight from Equal Weight with a price target of $220, up from $185. With a strong uptick in biopharma funding...

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.